Literature DB >> 31475305

Human papillomavirus (HPV) vaccine and autonomic disorders: a position statement from the American Autonomic Society.

Alexandru Barboi1,2, Christopher H Gibbons3, Felicia Axelrod4, Eduardo E Benarroch5, Italo Biaggioni6, Mark W Chapleau7, Gisela Chelimsky8, Thomas Chelimsky9, William P Cheshire10, Victoria E Claydon11, Roy Freeman3, David S Goldstein12, Michael J Joyner13, Horacio Kaufmann4, Phillip A Low5, Lucy Norcliffe-Kaufmann14, David Robertson6, Cyndya A Shibao6, Wolfgang Singer5, Howard Snapper15, Steven Vernino16, Satish R Raj6,17.   

Abstract

INTRODUCTION: Human papillomavirus (HPV) vaccination has been anecdotally connected to the development of dysautonomia, chronic fatigue, complex regional pain syndrome and postural tachycardia syndrome.
OBJECTIVES: To critically evaluate a potential connection between HPV vaccination and the above-noted conditions.
METHODS: We reviewed the literature containing the biology of the virus, pathophysiology of infection, epidemiology of associated cancers, indications of HPV vaccination, safety surveillance data and published reports linking HPV vaccination to autonomic disorders.
RESULTS: At this time, the American Autonomic Society finds that there are no data to support a causal relationship between HPV vaccination and CRPS, chronic fatigue, and postural tachycardia syndrome to other forms of dysautonomia.
CONCLUSION: Certain conditions are prevalent in the same populations that are vaccinated with the HPV vaccine (peri-pubertal males and females). This association, however, is an insufficient proof of causality.

Entities:  

Keywords:  Autonomic dysfunction; Consensus statement; HPV; Postural tachycardia syndrome; Vaccine

Mesh:

Substances:

Year:  2019        PMID: 31475305     DOI: 10.1007/s10286-019-00608-w

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  53 in total

1.  Making Vaccine Messaging Stick: Perceived Causal Instability as a Barrier to Effective Vaccine Messaging.

Authors:  Graham N Dixon
Journal:  J Health Commun       Date:  2017-07-06

2.  Response to letter to the editor.

Authors:  Louise Schouborg Brinth; Jesper Mehlsen
Journal:  Vaccine       Date:  2016-08-31       Impact factor: 3.641

3.  Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination.

Authors:  Yukitoshi Takahashi; Takashi Matsudaira; Hitoshi Nakano; Hirosato Nasu; Hitoshi Ikeda; Kentaro Nakaoka; Rumiko Takayama; Masayasu Oota
Journal:  J Neuroimmunol       Date:  2016-07-07       Impact factor: 3.478

4.  No increased risk of Guillain-Barré syndrome after human papilloma virus vaccine: A self-controlled case-series study in England.

Authors:  Nick Andrews; Julia Stowe; Elizabeth Miller
Journal:  Vaccine       Date:  2017-02-27       Impact factor: 3.641

Review 5.  Safety of Human Papillomavirus Vaccines: An Updated Review.

Authors:  Anastasia Phillips; Cyra Patel; Alexis Pillsbury; Julia Brotherton; Kristine Macartney
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

6.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

Review 7.  DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.

Authors:  I Jelihovschi; Aida Corina Bidescu; Simona Elena Tucaliuc; Luminiţa Smaranda Iancu
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  2015 Apr-Jun

Review 8.  Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review).

Authors:  Tina Dalianis
Journal:  Int J Oncol       Date:  2014-03-21       Impact factor: 5.650

Review 9.  Human papillomavirus molecular biology and disease association.

Authors:  John Doorbar; Nagayasu Egawa; Heather Griffin; Christian Kranjec; Isao Murakami
Journal:  Rev Med Virol       Date:  2015-03       Impact factor: 6.989

Review 10.  Model systems of human papillomavirus-associated disease.

Authors:  John Doorbar
Journal:  J Pathol       Date:  2015-12-10       Impact factor: 7.996

View more
  5 in total

1.  Response to: Human papillomavirus (HPV) vaccine safety concerning POTS, CRPS and related conditions.

Authors:  Alexandru Barboi; Christopher H Gibbons; Eduardo E Bennaroch; Italo Biaggioni; Mark W Chapleau; Gisela Chelimsky; Thomas Chelimsky; William P Cheshire; Victoria E Claydon; Roy Freeman; David S Goldstein; Michael J Joyner; Horacio Kaufmann; Phillip A Low; Lucy Norcliffe-Kaufmann; David Robertson; Cyndya A Shibao; Wolfgang Singer; Howard Snapper; Steven Vernino; Satish R Raj
Journal:  Clin Auton Res       Date:  2019-12-04       Impact factor: 4.435

Review 2.  Novel vaccine safety issues and areas that would benefit from further research.

Authors:  Daniel A Salmon; Paul Henri Lambert; Hanna M Nohynek; Julianne Gee; Umesh D Parashar; Jacqueline E Tate; Annelies Wilder-Smith; Kenneth Y Hartigan-Go; Peter G Smith; Patrick Louis F Zuber
Journal:  BMJ Glob Health       Date:  2021-05

3.  gAChR antibodies in children and adolescents with acquired autoimmune dysautonomia in Japan.

Authors:  Makoto Yamakawa; Mari Watari; Ken-Ichi Torii; Ichiro Kuki; Masashi Miharu; Momoko Kawazu; Akihiro Mukaino; Osamu Higuchi; Yasuhiro Maeda; Tokunori Ikeda; Koutaro Takamatsu; Nozomu Tawara; Keiichi Nakahara; Hidenori Matsuo; Mitsuharu Ueda; Takao Takahashi; Shunya Nakane
Journal:  Ann Clin Transl Neurol       Date:  2021-02-23       Impact factor: 4.511

4.  Association Between Human Papillomavirus Vaccination and Primary Ovarian Insufficiency in a Nationwide Cohort.

Authors:  Anders Hviid; Emilia Myrup Thiesson
Journal:  JAMA Netw Open       Date:  2021-08-02

5.  Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?

Authors:  Lawrence B Afrin; Tania T Dempsey; Leonard B Weinstock
Journal:  Vaccines (Basel)       Date:  2022-01-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.